RadHint

Mesenteric ischemia? (CTA)

CTWSES 2022

Pain out of proportion to examination, often with AF or a low-flow state; every hour of delay costs bowel.

Answer the surgeon

Emergent revascularization plus resection of non-viable bowel vs anticoagulation (venous) vs treating the low-flow state (NOMI).

Your answer must state:

  • Mechanism: SMA embolus (abrupt mid-SMA cutoff, no collaterals, AF) vs in-situ thrombosis (ostial, calcified plaque, collaterals) vs SMV thrombosis vs NOMI (diffuse narrowing, vasopressors)
  • Bowel viability: wall enhancement present or absent
  • Advanced bowel-injury signs: interpret pneumatosis and portomesenteric venous gas in context; identify frank perforation

Key and direct findings

Supportive signs & checks

Wet-read snippets

Fill the blanks, then copy into your preliminary report.

Positive

Acute mesenteric ischemia: ___ (SMA embolic occlusion ___ cm from origin / ostial SMA thrombosis / SMV thrombosis) with ___ bowel-wall enhancement of ___. Pneumatosis/portal venous gas: ___.

Negative

Patent SMA, SMV and celiac axis with normal bowel-wall enhancement — no CTA evidence of mesenteric ischemia.

Sources

Content review: Content pending clinical review · 2026-07-15

Educational reference for trained clinicians. Verify every result against the cited original guideline before use. Not a substitute for clinical judgment or medical advice.